FimmCyte Company

FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Industry: Pelvic & Uterine Healthcare
Headquarters: Basel, Basel-Stadt, Switzerland
Founded Date: 01-01-2022
Employees Number: 1-10
Investors Number: 3
Total Funding: $1,350,764
Last Funding Date: 2022-07-13
Last Funding Type: Grant

Visit Website
ms@fimmcyte.com
Register and Claim Ownership